This company is commonly known as Pandeia Therapeutics Limited. The company was founded 6 years ago and was given the registration number 11463856. The firm's registered office is in CAMBRIDGE. You can find them at C/o The Cambridge Partnership Ltd, The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge, . This company's SIC code is 72110 - Research and experimental development on biotechnology.
| Name | : | PANDEIA THERAPEUTICS LIMITED |
|---|---|---|
| Company Number | : | 11463856 |
| Company Type | : | PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital) |
| Status | : | Active |
| Incorporation Date | : | 13 July 2018 |
| End of financial year | : | 31 August 2022 |
| Jurisdiction | : | England - Wales |
| Industry Codes | : |
|
| Registered Address | : | C/o The Cambridge Partnership Ltd, The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge, United Kingdom, CB22 3FH |
|---|---|---|
| Country Origin | : | UNITED KINGDOM |
| Telephone | : | Unreported |
| Email Address | : | Unreported |
| Website | : | Unreported |
| Social | : | Unreported |
| Personal Information | Role | Appointed | Status |
|---|---|---|---|
| Moneta, Babraham Reserach Campus, Babraham, Cambridge, England, CB22 3AT | Corporate Secretary | 09 August 2019 | Active |
| C/O The Cambridge Partnership Ltd,, The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge, United Kingdom, CB22 3FH | Director | 22 December 2022 | Active |
| C/O The Cambridge Partnership Ltd,, The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge, United Kingdom, CB22 3FH | Director | 19 September 2019 | Active |
| C/O The Cambridge Partnership Ltd,, The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge, United Kingdom, CB22 3FH | Director | 19 September 2019 | Active |
| C/O The Cambridge Partnership, Moneta, Babraham Research Campus, Babraham, Cambridge, England, CB22 3AT | Director | 05 March 2019 | Active |
| C/O The Cambridge Partnership, Moneta, Babraham Research Campus, Babraham, Cambridge, England, CB22 3AT | Director | 05 March 2019 | Active |
| Biohub, Alderley Park, Macclesfield, England, SK10 4TG | Director | 13 July 2018 | Active |
| Acadia Pharmaceuticals Inc. | ||
| Notified on | : | 22 December 2022 |
|---|---|---|
| Status | : | Active |
| Country of residence | : | United States |
| Address | : | 12830, El Camino Real, San Diego, United States, |
| Nature of control | : |
|
| Medicxi Ventures I Lp | ||
| Notified on | : | 20 September 2019 |
|---|---|---|
| Status | : | Active |
| Country of residence | : | Jersey |
| Address | : | 44, Esplanade, St Helier, Jersey, Jersey, JE4 9WG |
| Nature of control | : |
|
| Dr Fraser Murray | ||
| Notified on | : | 05 March 2019 |
|---|---|---|
| Status | : | Active |
| Date of birth | : | May 1971 |
| Nationality | : | British |
| Country of residence | : | England |
| Address | : | C/O The Cambridge Partnership, Moneta, Babraham Research Campus, Cambridge, England, CB22 3AT |
| Nature of control | : |
|
| Dr Martin Quibell | ||
| Notified on | : | 05 March 2019 |
|---|---|---|
| Status | : | Active |
| Date of birth | : | July 1966 |
| Nationality | : | British |
| Country of residence | : | England |
| Address | : | C/O The Cambridge Partnership, Moneta, Babraham Research Campus, Cambridge, England, CB22 3AT |
| Nature of control | : |
|
| Dr Timothy Schulz-Utermoehl | ||
| Notified on | : | 13 July 2018 |
|---|---|---|
| Status | : | Active |
| Date of birth | : | October 1972 |
| Nationality | : | German |
| Country of residence | : | England |
| Address | : | C/O The Cambridge Partnership, Moneta, Babraham Research Campus, Cambridge, England, CB22 3AT |
| Nature of control | : |
|
Table of Contents
Nearby Companies
Copyright © 2025. All rights reserved.